IRIS
POMPILIO, ARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.494
EU - Europa 2.785
AS - Asia 1.164
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 7
AF - Africa 3
OC - Oceania 3
Totale 7.464
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.478
IT - Italia 575
IE - Irlanda 524
CN - Cina 510
UA - Ucraina 384
SE - Svezia 381
GB - Regno Unito 369
TR - Turchia 277
SG - Singapore 200
FR - Francia 176
DE - Germania 130
IN - India 93
RU - Federazione Russa 88
FI - Finlandia 74
VN - Vietnam 42
BE - Belgio 17
AT - Austria 13
CH - Svizzera 13
JP - Giappone 12
CZ - Repubblica Ceca 11
HK - Hong Kong 8
CA - Canada 7
EU - Europa 7
KR - Corea 7
MX - Messico 7
ES - Italia 6
BR - Brasile 5
NL - Olanda 5
IR - Iran 4
PL - Polonia 4
TH - Thailandia 4
GR - Grecia 3
BD - Bangladesh 2
BG - Bulgaria 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
PY - Paraguay 2
RS - Serbia 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AU - Australia 1
DK - Danimarca 1
IL - Israele 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MK - Macedonia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
RO - Romania 1
SC - Seychelles 1
ZA - Sudafrica 1
Totale 7.464
Salva come PNG Salva come JPEG
Città #
Chandler 835
Jacksonville 550
Dublin 519
Dearborn 281
Princeton 252
Southend 208
Ashburn 182
Chieti 162
Singapore 162
Nanjing 148
Izmir 142
Beijing 118
Wilmington 95
Ann Arbor 79
Cambridge 74
Altamura 68
Nanchang 48
Boardman 46
Dong Ket 42
Los Angeles 41
Santa Clara 38
Washington 38
Kunming 26
Hebei 25
Rome 25
New York 23
Shenyang 23
Jiaxing 22
Norwalk 22
Woodbridge 21
Tianjin 20
Brussels 16
Teramo 15
Pune 13
Vienna 13
Falls Church 12
Moscow 12
Changsha 10
Civitanova Marche 10
Houston 10
Kocaeli 10
Milan 10
Munich 10
Palermo 10
Pescara 10
Varallo 9
Chicago 8
Hefei 8
Hong Kong 8
Seattle 8
Grevenbroich 7
Guangzhou 7
Orange 7
Vittuone 7
Brno 6
Geneva 6
Lanzhou 6
Melfi 6
Napoli 6
Putignano 6
Augusta 5
Castel Gandolfo 5
Ferrara 5
Helsinki 5
Jinan 5
L'aquila 5
Monfalcone 5
Paris 5
San Mateo 5
Zurich 5
Bologna 4
Chennevières-sur-marne 4
Hangzhou 4
New Delhi 4
Shanghai 4
São Paulo 4
Tappahannock 4
Tehran 4
Udine 4
Amsterdam 3
Bari 3
Castellana Grotte 3
Catania 3
Delhi 3
Edinburgh 3
Florence 3
Lanciano 3
Molise 3
Montreal 3
Ningbo 3
Orsogna 3
Perugia 3
Redwood City 3
Taizhou 3
Terranuova Bracciolini 3
Tokyo 3
Trieste 3
Warsaw 3
Zhengzhou 3
Acquaviva Delle Fonti 2
Totale 4.749
Salva come PNG Salva come JPEG
Nome #
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp. pasteurianus 185
Attività battericida ed anti-biofilm di peptidi antimicrobici verso patogeni multi-resistenti isolati da pazienti con fibrosi cistica. 123
Fatal sepsis by Klebsiella pneumoniae in a patient with systemic lupus erythematosus: the importance of postmortem microbiological examination for the ex post diagnosis of infection. 116
Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance. 107
Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm 99
Helicobacter pylori ATCC 43629/NCTC 11639 Outer Membrane Vesicles (OMVs) from Biofilm and Planktonic Phase Associated with Extracellular DNA (eDNA). 97
Meticillin-heteroresistant Staphylococcus pasteuri from an apheresis platelet product 93
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis 92
Colonic adenoma-associated Escherichia coli express specific phenotypes 89
Role of excessive inflammatory response to Stenotrophomonas maltophilia lung infection in DBA/2 mice and implications for cystic fibrosis. 87
Misidentification of ampicillin-sulbactam heteroresistance in Acinetobacter baumannii strains from ICU patients 84
Risk of misidentification of Enterobacter aerogenes inducible cephalosporinases. 84
Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. 84
In vitro microbiology studies on a new peritoneal dialysis connector 81
Effetto di concentrazioni sub-inibenti di moxifloxacina su Stenotrophomonas maltophilia isolati da fibrosi cistica 80
Analisi proteomica del biofilm formato da un ceppo di Stenotrophomonas maltophilia isolato da fibrosi cistica. 80
Pan-azole-resistant Candida guilliermondii from a leukemia patient's silent funguria 79
Effect of environmental factors on biofilm formation by clinical Stenotrophomonas maltophilia strains. 78
Determination of ciprofloxacin and levofloxacin in human sputum collected from cystic fibrosis patients using microextraction by packed sorbent-high performance liquid chromatography photodiode array detector 78
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 78
Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient 78
An overview of various typing methods for clinical epidemiology of the emerging pathogen Stenotrophomonas maltophilia. 78
Adhesion and biofilm formation by Staphylococcus aureus clinical isolates under conditions relevant to the host: Relationship with macrolide resistance and clonal lineages 78
Serum and mucosal cytokine profiles in patients with active Helicobacter pylori and ischemic heart disease: is their a relationship ? 77
Antibiotic resistance and biofilm in Stenotrophomonas maltophilia isolates from cystic fibrosis and non-cystic fibrosis patients 76
Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study 76
Myroides odoratimimus Forms Structurally Complex and Inherently Antibiotic-Resistant Biofilm in a Wound-Like in vitro Model. 76
Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus 75
Infection of recurrent calcaneal ulcer caused by a biofilm-producer Myroides odoratimimus strain. 75
In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression 75
Cell surface hydrophobicity, motility, and biofilm formation of Stenotrophomonas maltophilia clinical isolates. 74
Isolation of colistin-resistant Hafnia alvei. 74
Eparina sodica stimola la formazione di biofilm da parte di Providencia stuartii. 73
Subinhibitory concentrations ofmoxifloxacin decrease adhesion and biofilm formation of Stenotrophomonasmaltophilia from cystic fibrosis. 73
Peptide dendrimers as “lead compounds” for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: In vitro and in vivo studies 73
An overview on streptococcus bovis/streptococcus equinus complex isolates: Identification to the species/subspecies level and antibiotic resistance 73
Anaerobiosi ed ambiente acido influenzano l’attività in vitro di colistina nei confronti del biofilm formato da ceppi di Pseudomonas aeruginosa isolati da pazienti affetti da fibrosi cistica. 72
Stenotrophomonas maltophilia virulence and specific variations in trace elements during acute lung infection: implications in cystic fibrosis. 72
Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence. 71
Multidrug-resistant Geotrichum capitatum from a haematology ward. 70
In vitro bactericidal and antibiofilm activity of six antimicrobial peptides against multidrug-resistant pathogens from patients with cystic fibrosis. 70
Alterazione dei livelli tessutali di ioni metallici in un modello murino di infezione polmonare da Stenotrophomonas maltophilia. 70
A novel biotechnology product for the degradation of biofilm-associated polysaccharides produced by Streptococcus mutans 70
Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients. 70
Disomeostasi cationica in un modello murino di infezione polmonare da Stenotrophomonas maltophilia 69
Haemophilus influenzae in children with cystic fibrosis: antimicrobial susceptibility, molecular epidemiology, distribution of adhesins and biofilm formation. 68
Exposure to extremely low-frequency magnetic field affects biofilm formation by cystic fibrosis pathogens 68
Determinazione di Ciprofloxacina e Levofloxacina in espettorato da pazienti affetti da fibrosis cistica mediante MEPS-HPLC-PDA 68
D-BMAP18 Antimicrobial Peptide Is Active In vitro, Resists to Pulmonary Proteases but Loses Its Activity in a Murine Model of Pseudomonas aeruginosa Lung Infection 68
Stenotrophomonas maltophilia mutant lacking flagella remains virulent in DBA/2N mice but is less efficient in stimulating TNF-α expression 68
Tuberculosis-like pneumonias by the aerobic actinomycetes Rhodococcus, Tsukamurella and Gordonia. 67
Factors associated with adherence to and biofilm formation on polystyrene byStenotrophomonas maltophilia: the role of cell surface hydrophobicity and motility. 66
Helicobacter pylori Outer Membrane Vesicles (OMVs) as DNA shuttles and structural components of biofilm EPS 66
New insights in Staphylococcus pseudintermedius pathogenicity: Antibiotic-resistant biofilm formation by a human wound-associated strain 66
In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under "cystic fibrosis-like" physicochemical conditions 64
V240H replacement, by site-directed mutagenesis, increases resistance toward carbapenems in TEM-149 ESBL producing E. coli. 63
Ruolo epidemiologico del biofilm in isolati di Stenotrophomonas maltophilia da pazienti con fibrosi cistica e da pazienti ricoverati in unità di terapia intensiva 63
Staphylococcus pasteuri bacteraemia in a patient with leukaemia. 62
Attvità antibatterica ed anti-biofilm del peptide P19(9/B) verso isolati multi-resistenti isolati da pazienti affetti da fibrosi cistica 62
Studio microbiologico in vitro su di un nuovo connettore per dialisi peritoneale 62
Normal breathing releases SARS-CoV-2 into the air 62
Comparative evaluation of the Vitek-2 Compact and Phoenix systems for rapid identification and antibiotic susceptibility testing directly from blood cultures of Gram-negative and Gram-positive isolates. 61
Hafnia alvei from the farm to the delivery room 61
Chloramphenicol and rifampin may be the only options against Stenotrophomonas maltophilia. A tale of a colonized bladder device in a patient with myelofibrosis. 60
Evaluation of in vitro activity of ceftolozane-tazobactam compared to other antimicrobial agents against Pseudomonas aeruginosa isolates from cystic fibrosis patients 60
Bacterial contamination of platelets and septic transfusions: review of the literature and discussion on recent patents about biofilm treatment. 59
Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. 59
An antimicrobial bicyclic peptide from chemical space against multidrug resistant Gram-negative bacteria 59
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 59
Effect of levofloxacin on Stenotrophomonas maltophilia biofilm and its relationship with SmeDEF multidrug efflux pump expression under conditions relevant to the cystic fibrosis lung 59
A new challenge in cystic fibrosis antimicrobial therapy: activity of electrochemically synthesized silver nanoparticles against planktonic and biofilm cells of bacterial pathogens 59
Characterization of biofilm formation by Myroides odoratimimus isolated from post-traumatic calcaneal recurrent ulcer in diabetic patient 59
Patogenesi in fibrosi cistica: clearance di Stenotrophomonas maltophilia ed infiammazione in un modello murino di infezione polmonare. 58
A cystic fibrosis child with lung function decline 58
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp pasteurianus 58
Formazione di biofilm, diversità genetica e virulenza in Stenotrophomonas maltophilia isolati da pazienti con fibrosi cistica. 56
Antimicrobial and antibiofilm activity of secondary metabolites of lichens against methicillin-resistant Staphylococcus aureus strains from cystic fibrosis patients. 56
Corynebacterium glucuronolyticum causing genitourinary tract infection: Case report and review of the literature 56
Identification of CTX-M-15 and CTX-M-27 in Antibiotic-Resistant Gram-Negative Bacteria Isolated from Three Rivers Running in Central Italy 56
ONE-STEP DEPOSITION METHOD FOR THE SYNTHESIS OF A NANOCOMPOSITE MEMBRANE BASED ON REDUCED GRAPHENE OXIDE/ZEOLITE-A FOR ADSORPTION OF METAL IONS WITH ENHANCED ANTIBACTERIAL PROPERTIES 55
Microbial cooperation in cystic fibrosis: Stenotrophomonas maltophilia significantly modulates Pseudomonas aeruginosa virulence. 55
Stenotrophomonas maltophilia phenotypic and genotypic diversity during a 10-year infection in the lungs of a cystic fibrosis patient 55
New insights in Staphylococcus pseudintermedius pathogenicity: antibiotic-resistant biofilm formed by a human wound-associated strain. 54
Clonal diversity, biofilm formation, and antimicrobial resistance among Stenotrophomonas maltophilia strains from cystic fibrosis and non-cystic fibrosis patients 54
Modulation of biofilm formation by Stenotrophomonas maltophilia during chronic lung infection in cystic fibrosis patients: a longitudinal population study 54
The anti-microbial peptide (Lin-SB056-1)2-K reduces pro-inflammatory cytokine release through interaction with Pseudomonas aeruginosa lipopolysaccharide 54
Olive Pâté by Multi-Phase Decanter as Potential Source of Bioactive Compounds of Both Nutraceutical and Anticancer Effects 54
Molecular genotyping, adhesion and biofilm formation in methicillin-resistant Staphylococcus aureus clinical strains. 53
In vitro bactericidal and anti-biofilm activity of bovine myeloid antimicrobial peptides against multidrug-resistant bacteria from patients with cystic fibrosis. 52
Attvità antibatterica ed anti-biofilm di BMAP-27 e BMAP-28 verso ceppi multi-resistenti isolati da pazienti affetti da fibrosi cistica 52
An ultrathin film membrane based on a nano-channeled reduced graphene oxide with enhanced antibacterial properties 51
null 51
“Indirect pathogenicity” in cystic fibrosis during pulmonary exacerbations: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in a Galleria mellonella model. 50
Biofilm formation and antibiotic resistance in Stenotrophomonas maltophilia: a prospective multicentre study 50
Ambient air pollution and respiratory bacterial infections, a troubling association: epidemiology, underlying mechanisms, and future challenges 50
Ruolo della componente flagellare nella patogenicità di Stenotrophomonas maltophilia in fibrosi cistica. 49
Interazione in vitro tra Stenotrophomonas maltophilia e cellule epiteliali bronchiali IB3-1: implicazioni in fibrosi cistica. 48
Genotipizzazione e formazione di biofilm in isolati clinici diStaphylococcus aureus eritromicina-resistenti. 48
Antidiabetic “gliptins” affect biofilm formation by Streptococcus mutans 48
Efficacy of phages and antibiotic-phage combinations against biofilm by Pseudomonas aeruginosa from cystic fibrosis patients 48
Totale 6.913
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.954
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.954
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.191 0 77 29 21 182 170 202 118 52 136 184 20
2020/2021751 105 18 150 25 56 135 13 18 40 98 24 69
2021/2022828 27 39 31 121 60 22 35 62 85 20 94 232
2022/20232.073 179 270 156 248 184 384 105 152 254 25 83 33
2023/2024918 61 50 79 33 80 250 194 47 12 25 8 79
2024/2025390 119 271 0 0 0 0 0 0 0 0 0 0
Totale 8.106